Scientific Program

Conference Series Ltd invites all the participants across the globe to attend 2nd International Conference on Cardiovascular Medicine and Cardiac Surgery London, UK.

Submit your Abstract
or e-mail to

[email protected]
[email protected]
[email protected]

Day 2 :

Keynote Forum

William J Rowe

University of Toledo Medical Center, USA

Keynote: Neil armstrong syndrome and thermoregulation

Time : 09:10-09:50

OMICS International Cardiovascular 2017 International Conference Keynote Speaker William J Rowe photo
Biography:

William J Rowe is a board certified Specialist in Internal Medicine. He completed his MD at University of Cincinnati and was in private practice in Toledo, Ohio for 34 years.  He was a former Assistant Clinical Professor of Medicine at University of Ohio, School of Medicine. Out of four space syndromes, he has published two: The Apollo 15 Space Syndrome and Neil Armstrong Syndrome.

Abstract:

Neil Armstrong syndrome triggered by very common earth related magnesium (Mg) deficits, invariably with spaces flight (SF); invariable dehydration with exercise-induced sweating with Mg loss and through kidneys; leaks of plasma through oxidative stress-induced defective capillaries; loss of thirst mechanism; in turn, angiotensin, catecholamine (C) elevations to twice earth levels when supine; vicious cycles with Mg ion deficits; can trigger C cardiomyopathy i.e. acute temporary heart failure. Normal earth CO2 levels about 0.03% with SF, levels can be 0.5-7% as on Mir; this, postulated to trigger calcium (Ca) overload with in turn coronary vasospasm, injuries to mitochondria along with impairment in telomere function; its synthesis is dependent upon Mg and in turn, decreased cardiac function. Since Mg required for thermoregulation was intensified by SF-exercise for at least 2 hours exercise/day; invariable SF mal-absorption with Mg levels reduced to p<0.0001 even though serum Mg lacks sensitivity. Neil Armstrong informed Houston twice at 4 minutes interval, of shortness of breath with heart rate up to 160 (tachycardia conducive to oxidative stress) with marked reduction to 60, half hour before pacific-splashdown over three days later; severe thirst, quenched with in turn, reduced postulated high C. Mg is powerful antioxidant and Ca blocker. Severe dyspnea, thirst, tachycardia; the latter, corrected by water replenishment during three days back to Earth; one of only four- SF syndromes was observed; applicable to Earth in post-menopausal women, particularly if taking Ca supplements which reduces Mg absorption; marathoners at finish line; in tropics with water shortages; may be corrected quickly with I.V fluids or subcutaneous Mg.

OMICS International Cardiovascular 2017 International Conference Keynote Speaker Yehuda Adler photo
Biography:

Yehuda Adler is Director of Development of Medical Resource, Director of Internship Committee, Director of the Talpiot Medical Leadership Program (a revolutionary program to build medical leadership in Israel),  and Director of health professions at the Chaim Sheba Medical Centre, Israel. He is a member of the National Council for Prevention and Treatment of Cardiovascular Diseases at the Ministry of Health in Israel. He is also a Vice Chair of the Nucleus, The ESC's Committee for Myocardial and Pericardial diseases.  He wrote the ESC Guidelines for pericardial disease in 2005 and chaired the ESC Guidelines for pericardial disease in 2015. In the past, he served as General Director at Misgav-Ladach Hospital, Jerusalem, Israel. He has published over 200 original articles in leading professional medical and research journals throughout the world and is an active participant and speaker in international scientific meetings.

Abstract:

There are limited contemporary data regarding the association between improvement in cardiovascular fitness in heart failure (HF) patients who participate in exercise training and the risk for subsequent hospitalizations. Shown in the presentation are the connections between exercise training and skeletal muscle in CHF; the anti-inflammatory effects of exercise training in CHF and the hemodynamic effects of exercise training in CHF (which includes general hemodynamics, endothelial function and small vessels). In addition, pathobiological pathways induced by exercise training in patients with heart failure are displayed. The essential details from research done by David J. Whellan (Jefferson Medical College, Philadelphia, PA) and Christopher M. O'Connor (Duke University Medical Center, Durham, NC) titled: “Efficacy and safety of exercise training as a treatment modality in patients with chronic heart failure” are displayed. Results of a randomized controlled trial investigating outcomes of exercise training (HF-ACTION) are shown as well. Cardiac insufficiency with preserved systolic function; prevailing manifestation of evaluation diastolic impairment using ratio of volume/pressure and pharmaceutical treatment was checked or is being checked on perspective oriented projects. Results regarding exercise capacity, diastolic function & la remodeling and the quality of life are reviewed. In summary, the colleague team work that plays an important role in the field is reflected. Heart failure patients participating in exercise training for improvement of cardiovascular fitness are associated with reduced risk of mortality or hospitalization during long-term follow-up, independent of their baseline fitness.

Keynote Forum

Samer Ellahham

Sheikh Khalifa Medical City, UAE Cleveland Clinic, USA

Keynote: HFpEF: Cardiovascular abnormalities not just comorbidities

Time : 10:45-11:25

OMICS International Cardiovascular 2017 International Conference Keynote Speaker Samer Ellahham photo
Biography:

Samer Ellahham has served as Chief Quality Officer at Shaikh Khalifa Medical City since 2009. In his role, he has led the development of a quality and safety program that has been highly successful and visible and has been recognized internationally by a number of awards. As Chief Quality Officer and Global Leader, he has focus on ensuring that that implementation of this best practices leads to breakthrough improvements in clinical quality and patient safety. He is the recipient of the Quality Leadership Award from the Global Awards for Excellence in Quality and Leadership and the Business Leadership Excellence Award from the World Leadership Congress. He was nominated in 2015 for SafeCare magazine Person of the Year.  He is a recognized leader in quality, safety, and the use of robust performance improvement in improving healthcare delivery.

Abstract:

Nearly half of all patients with heart failure have a normal ejection fraction (EF). The prevalence of this syndrome, termed heart failure with preserved ejection fraction (HFpEF), continues to increase likely because of the increasing prevalence of common risk factors, including older age, female gender, hypertension, renal dysfunction, metabolic syndrome and obesity. In contrast to heart failure with reduced ejection fraction (HFrEF), no treatment has been proven in pivotal clinical trials to be effective for HFpEF, largely because of the pathophysiological heterogeneity that exists within the broad spectrum of HFpEF. This syndrome was historically considered to be caused exclusively by left ventricular diastolic dysfunction but research has identified several other contributory factors, including limitations in left ventricular systolic reserve, systemic and pulmonary vascular function, nitric oxide bioavailability, chronotropic reserve, right heart function, autonomic tone, left atrial function and peripheral impairments. Multiple individual mechanisms frequently coexist within the same patient to cause symptomatic heart failure, but between patients with HFpEF the extent to which each component is operative can differ widely, confounding treatment approaches. Clinical trials have not yet identified effective treatments for HFpEF. Incomplete understanding of the pathophysiology of HFpEF, the likelihood that there is substantial pathophysiologic heterogeneity among affected patients and the interplay of various risk factors has all been barriers in the development of effective treatments. Ongoing research initiatives are critically important as there is a rapid increase in number of patients with this form of heart failure.

Learning Objectives: Objectives are to: Demonstrate the association between heart failure with preserved ejection fraction (HFpEF) and survival; given a patient with heart failure (HF), recognize HFpEF on the basis of clinical signs and symptoms, physical examination, echocardiography, and radiographic findings; classify patients at high risk of hospitalization and mortality through assessing risk factors, clinical presentation and interpretation of biomarkers; distinguish the clinical presentation, diagnosis and treatment strategies of HFpEF from those of HF with reduced.ejection fractiongiven a patient with HFpEF, develop an individualized treatment plan based on current evidence; assess the potential role of future pharmacotherapies for HFpEF.

  • Congestive Heart Failure|Research on Cardiology | Cardiomyopathy | Hypertension | Coronary Artery Bypass Graft Surgery
Speaker

Chair

Mridula Dhakad

Saudi German Hospital, UAE

Speaker

Co-Chair

Barbara Petracci

Policlinico San Matteo IRCCS, Italy

Session Introduction

Barbara Petracci

Policlinico San Matteo IRCCS, Italy

Title: Adaptive-ness and effective-ness: The two primary goals to achieve in CRT

Time : 11:25-11:55

Speaker
Biography:

Barbara Petracci is a Medical Doctor in Department of Cardiology, University of Pavia, Italy. She is mainly involved in the clinical activity of the Pacing and Electrophysiology Unit of the Department of Cardiology of the IRCCS San Matteo Hospital. As first operator, she usually performs pacemaker and defibrillator implantation procedures, including devices for cardiac resynchronization therapy, and catheter ablation of cardiac arrhythmias, including atrial fibrillation and ventricular tachycardia ablation. She is an experienced operator in laser catheters extraction. She is a member of the Italian Society of Pediatric Cardiology and Congenital Cardiomyopathy (SICP), a member of the Italian Association of Hospital Cardiologist (ANMCO), a member of the European Heart Rhythm Association (EHRA) and a member of the Italian Association of Arrhythmology and Cardiac Pacing.

Abstract:

Cardiac Resynchronization Therapy (CRT) is known as a highly effective therapy in advanced heart failure patients with cardiac dissinchrony. However, still one third of patients do not fully respond to CRT. Among the many contributors for the high rate of non-responders, the lack of procedures dedicated to CRT device settings optimization is known as one of the most frequent. On the other side, the echocardiography optimization is not widely used in the real world of CRT follow up visits. Thus, device-based techniques have been developed to by-pass the need of repeated echo evaluations to optimize CRT settings. There are multiple drivers of non-response. Common factors are AV/VV timing, reduced BiV pacing, LV lead placement, presence of arrhythmias, appropriate patient selection, patient compliance and presence of comorbidities. The current challenge facing practitioners is to maximize the rate of patients who respond to CRT and the magnitude of the response. A very particular and important subgroup of HF population with CRT includes the patients with AF since the optimal use of CRT in this cluster remains uncertain. The current area of interest achieving these goals includes the tailoring patients’ selection, the individualizing LV placement and, in particular, the application of new technologies and algorithms for CRT delivery in optimal fashion, reducing inappropriate shocks incidence and optimizing device longevity.

Break: Networking & Refreshment Break 11:00-11:15 @ Foyer
Speaker
Biography:

Qiuping Zhang has her expertise in “Nesprin family research in Cardiovascular Biology field, specifically on understanding the complex roles of nesprin-1 and -2, family members of multi-isomeric scaffolding proteins, in regulating normal and pathological processes in the heart and muscle”. She has studied extensively the role of nesprins in myoblast differentiation and function as well as mutations in nesprin-1 or -2 in associations with Emery Dreifuss muscular dystrophy and dilated cardiomyopathy. Her current research focuses on “Defining the roles of nesprins in cardiac cell function by determining the functional significance of novel nesprin-1 and -2 mutations on the linker of nucleoskeleton-and-cytoskeleton complex that connects the nuclear envelope to the actin cytoskeleton, and also identifying novel roles for nesprins in the sarcomere”. This may reveal novel pathways that contribute to the development of cardiac cell dysfunction and cardiomyopathy.

Abstract:

Nesprins-1 and -2 are highly expressed in skeletal and cardiac muscle and together with SUN (Sad1p/UNC84)-domain containing proteins and lamin A/C form the linker of nucleoskeleton and cytoskeleton (LINC) bridging complex at the nuclear envelope (NE). Mutations in nesprin-1 and -2 have previously been found in patients with autosomal dominant Emery-Dreifuss muscular dystrophy 4 (AD-EDMD 4, OMIM 612998) and 5 (AD-EDMD5, OMIM 612999) as well as dilated cardiomyopathy (DCM). In this study, three novel rare variants (R8272Q, S8381C and N8406K) in the C-terminus of the SYNE-1 gene (nesprin-1) were identified in 7 DCM patients by mutation screening. Expression of these mutants caused nuclear morphology defects and reduced lamin A/C and SUN2 staining at the NE. GST-pull down indicated that nesprin-1/lamin/SUN interactions were disrupted. Nesprin-1 mutations were also associated with augmented activation of the ERK pathway in vitro and in hearts in vivo. During C2C12 muscle cell differentiation, nesprin-1 levels are increased concomitantly with kinesin light chain (KLC-1/2), and immunoprecipitation and GST-pull down showed that these proteins interacted via a recently identified LEWD domain in the C-terminus of nesprin-1. Expression of nesprin-1 mutants in C2C12 cells caused defects in myoblast differentiation and fusion associated with dysregulation of myogenic transcription factors and disruption of the nesprin-1 and KLC-1/2 interaction at the outer nuclear membrane. These findings support a role for nesprin-1 in myogenesis and muscle disease, and uncover a novel mechanism whereby disruption of the LINC complex may contribute to the pathogenesis of DCM.

Speaker
Biography:

Sherif A S A Mansour is a Consultant of Cardiothoracic Surgery in Ministry of Health Hospitals, in addition to working as a Surgeon in Royal Stoke Hospital, Stoke-on-Trent, UK. He works at the Ain Shams University in Cairo, Egypt as a Senior Lecturer. He is subspecialized in Off Pump CABG, minimal invasive cardiac surgery with fantastic results and many contributions to various cardiac surgery centers in the Middle East, Asia and Africa. He shared in the establishment of more than one cardiac surgery center across Egypt with training of the staff and the surgical assistants and registrars. He also had publications in the peer reviewed journals and contributions in some published cardiothoracic books with many contributions at international conferences across Europe and Asia. Recently, he started to explore the field of Robotic Heart Surgery with strong steps toward achieving his goal of mastering it.

Abstract:

Introduction & Objective: Sildenafil (phosphodiesterase inhibitor type 5) has been successfully used to treat primary pulmonary hypertension. Mitral valve disease notably stenotic lesion is a long standing disease, in developing countries late detection results in increase association with severe secondary (PAH) pulmonary hypertension. Right ventricular (RV) failure is a leading cause of increased morbidity and mortality of patients with severe pulmonary hypertension undergoing mitral valve surgery. The study aims to confirm the effectiveness of preoperative oral sildenafil in decreasing the incidence of RV failure in this category of patients.

Methods: Eighty patients scheduled for mitral valve replacement surgery with severe PAH, RV systolic pressure (RVSP) ≥60mmHg were included in the study. Patients were randomized into two groups: Gr C - placebo (N=40), and Gr S - Sildenafil (N=40) with oral sildenafil 25 mg eight hourly for 48 h before surgery with the last dose given 25 mg in 10 ml via nasogastric tube after induction of anesthesia. In both group the need for inotropes was recorded and doses were titrated to achieve hemodynamic stability during and after cardiopulmonary bypass (CPB).

Results: Pulmonary artery pressure was significantly reduced in the sildenafil group. Ventilation time was less in the sildenafil group but without statically significant value, CPB time was significantly lower in the sildenafil group (p=0.05) and postoperative ITU stay was significantly lower (P<0.001) in sildenafil group. The requirements of inotropes notably dobutrex and milrinone were significantly more with placebo group compared to sildenafil group.

Conclusions: It is concluded that sildenafil is safe and effective in reducing severe pulmonary hypertension when given to patients prior to the mitral valve replacement surgery; which facilitated weaning from CPB.

Break: Lunch Break: 12:55-13:55 @ W5 Grill Restaurant

Mridula Dhakad

Saudi German Hospital, UAE

Title: Interesting case presentation in Aortic Dissection

Time : 15:00-15:30

Speaker
Biography:

Mridula Dhakad is a senior interventional Cardiologist with more than 25 years of experience in Interventional and Clinical Cardiology. She has actively participated in many national and international conferences. She has been extensively involved in treating many complex and critical cardiac patients. She has received her interventional training at well reputed large public and private hospitals. She did her fellowship in Interventional Cardiology at a world renowned large volume centre at Paris. She was instrumental in establishing Cardiology department at various reputed institutions. She is an active member of European Society of Cardiology and a life member of Cardiology.

Abstract:

Aortic dissection has varying presentations. This disease entity can mimic other acute emergencies posing a diagnostic dilemma. There should be high index of suspicion in diagnosing aortic dissection in patients of all ages. With newer advanced modalities of diagnosis and the risk score algorithms, the clinical outcome of an otherwise catastrophic disease has improved to a great extent. All the patients of collagen disease, bicuspid aortic valve, coarctation of aorta, uncontrolled HT and unexplained AR should be thoroughly evaluated. This interesting case of a 73 year old elderly gentleman presented with sudden onset chest discomfort radiating to the jaw with a short episode of sudden shortness of breath. The physical examination was unremarkable with stable hemodynamics and well felt peripheral pulses with no discrepancy. His D dimers were found to be markedly elevated with raised serum creatinine. The cardiac enzymes were normal. ECG was not indicative of myocardial ischemia. Echo showed minimal AR, mild anterolateral pericardial effusion with good LV systolic function and PA pressure of 32 mm Hg. He was hyper-tensed on medication with history of CVA 3 years ago and was on Warfarin since then. He remained stable hemodynamically for the initial 24 hours after admission, later he developed atrial fibrillation with controlled ventricular response. Owing to renal dysfunction, instead of pulmonary CT angiography, VQ scan was done to rule out pulmonary embolism. It revealed multiple perfusion defects in both lung fields. Simultaneous repeat echocardiography revealed increase in grade of AR to more than 1/4 and mild increase in PE with echogenicity seen within the effusion behind RV (possibly blood). CT chest was immediately performed which clinched the diagnosis of type A aortic dissection. He was immediately referred to the cardiac surgeon who did emergency surgical correction with successful recovery.

Amjed Eljaili

Betsi Cadwalader University Health Board, UK

Title: Left ventricular thrombus complicated by acute stroke due to consequence of cocaine abuse

Time : 15:30-16:00

Speaker
Biography:

Amjed Eljaili, MBBS  October 2010, University of  Al-Zaiem Al-Azhari, Sudan, currently practicing in  UK , Wales deanery , foundation year-2 trainee, BCUHB, emergency department, Ysbyty Gwynedd,   He attended several a cademic meetings, regionally and nationally, He has participated in various national work-shops, congress.  participation and membership with  British institute of Radiology, UK.

Abstract:

Cocaine abuse can cause acute and chronic cardiovascular complications which include, coronary artery spasm , aortic dissection,  myocardial infraction, left ventricular dysfunction and  thrombosis that  can  lead to fatal thromboembolic event.  It has been well described in the literature that  cocaine  significanlty  increases the risk of  ischemic stroke  in young adults within 24 hours of use. Interestingly  the risk of cerebral infarct  relating  to acute cocaine comsuption  is notably  higher  than the usuall well known  stroke  risk factors.

A 32 years old gentleman  who is known to have history of  cocaine abuse, presented  with an acute stroke, myocardial infraction and significant large left ventricular thrombus which took place within  short time window following cocaine abuse.

Break: Lunch Break: 13:15-14:15 @ W5 Grill Restaurant

Arunkumar Arasappa

Sri Manakula Vinayagar Medical College and Hospital, India

Title: Establishing a cardiac programme in rural or semiurban places - Feasible or not?

Time : 16:15-16:45

Speaker
Biography:

Arunkumar Arasappa is a Consultant Cardiothoracic Surgeon and is an Assistant Professor in the Department of Cardiothoracic Surgery at Sri Manakula Vinayagar Medical College and Hospital, Pondicherry. He started the Department of Cardiothoracic Surgery in this Medical College Hospital which is located in a village called kalitheerthalkuppam, Pondicherry, India. We have started this cardiothoracic program and open heart surgeries since April 2016 onwards till date. His team has successfully completed more than 90 open heart surgeries in a span of 10 months which includes beating heart CABG, On-Pump CABG, valvular heart surgeries and both adult and pediatric congenital heart surgeries.

Abstract:

To discuss the feasibility of starting and establishing a superspecialty department like cardiothoracic surgery in rural and semi-urban centers is a herculean task. We planned to setup a pilot project on how to start a superspecialty department in Rural and semiurban places and also to do open heart surgical procedures at an affordable cost. We discussed our plan with a medical college hospital in our locality and they helped us to start this within their premises with available infrastructure. We closely followed up the inpatient crowd of the hospital and secured cases from all fields of medicine and especially from cardiology department. We managed to maintain a registry of cases and categorized patients based on their symptoms and who needed surgery. Our next task of building the infrastructure was aimed and we procured materials necessary to start this program which included setting up of operation theatre, CT ICU and postoperative wards. Our other task of recruiting staffs for caring the patients was breathtaking and was managed successfully. After establishing this we started our first open heart procedure on April 2016 and continued from thereon. Today, we had crossed more than 90 open heart surgeries apart from vascular and thoracic surgeries. We have now established a center which can perform all cardiac surgery programs that are done at any standard hospitals or medical colleges in major cities. Today we proudly say that the task is well started and could be achieved with the help of a supporting team of dedicated doctors and paramedical staffs and equally supported with the necessary infrastructure by the hospital to cater the underprivileged people with the support of various schemes and insurance assistance.

Speaker
Biography:

To be updated soon...

Abstract:

Statement of the Problem: Mitral valve can be accessed through left atrium or via inter-atrial septum. Although left atrium is the traditional approach, trans-septal approach gives better exposure in difficult cases. This retrospective study was designed to evaluate the safety, pitfalls and effectiveness of the extended vertical trans-septal approach for routine mitral valve exposure.

Methodology & Theoretical Orientation: It is a retrospective study of 1017 consecutive patients undergoing an isolated primary mitral valve procedure (repair, replacement) through a median sternotomy between the years 2000 and 2015 by eight different surgeons. Out of these 135 patients were operated by extended vertical trans-septal approach (EVTSA, group A) while 882 patients were accessed through traditional left atrial (LA, group B) approach via posterior inter-atrial groove.

Findings: There were 135 patients (M/F=56/79) in group A and 882 patients (M/F=398/484) in group B. Logistic euro score was significantly lower in EVTSA group (0.61 vs. 0.90 p=0.000001). In LA group, there were more patients with pre-operative TIA or stroke (94 vs. 6 p=0.005), and this difference was statistically significant. Cumulative cross clamp time was 82 (44-212) minutes (EVTSA) and 78 (30-360) minutes (LA) groups (p=0.271) while cardiopulmonary bypass time was 107 (58-290) and 114 (43-602) minutes (p=0.121). Post-operative blood loss was 415 ml (EVTSA) versus 427 (LA) ml (p=0.273). No significant difference was found in the incidence of post-operative atrial fibrillation (p=0.22) or heart block requiring permanent pacemaker (p=0.14).

Conclusion & Significance: Extended vertical trans-septal approach is safe and reproducible. It gives excellent exposure of the mitral valve. It is reasonable way to routinely expose mitral valve without significant increase in cross clamp time, post-operative arrhythmia, heart block or bleeding.

Biography:

Sarwat Sultan is the Chairperson of the Department of Applied Psychology, BZU, Pakistan. She has done her PhD in Applied Psychology in 2009, and has completed her Post-doctorate from Curtin University, Australia in 2013. She is serving the Department of Applied Psychology, Bahauddin Zakariya University Multan since the last 15 years. She has contributed more than 75 research articles in national and international journals, has presented more than 60 papers in conferences at national and International levels, and has supervised more than 150 dissertations. She has one book published in Germany to her credit. She is a distinguished teacher having experience of research and psychological testing and interventions. 

Abstract:

Statement of the Problem: The purpose of this study was to assess the effectiveness of cognitive behavioral couple therapy (CBCT) in treating heart disease by managing marital conflict among female patients with coronary heart disease.

Methodology: This study was completed using repeated measure design with a sample of 20 female cardiac patients approached at Institute of Cardiology Multan who were matched on the characteristics of age, education and economic class. This sample was then randomly assigned to the intervention (n=10) and control groups (n=10). CBCT was administered to the intervention group (n-10) while control group was on medication only. Data were collected on measures of Kansas Marital Satisfaction (KMS) Scale, Revised Dyadic Adjustment Scale (RDAS) and coronary heart disease symptoms check list (CHDS) from both groups before and after the administration of CBCT to intervention group. The data were analyzed by employing Kolmogorov-Smirnov test, Mann-Whitney U test and Wilcoxon W test.

Findings: Significant differences were found in pre and post scores on marital satisfaction scale, dyadic adjustment scale and symptoms of CHD for intervention group. The CBCT was found to be effective in increasing stability and satisfaction in the marital relationship of females. Female Patients after CBCT also reported a decrease in their symptoms of CHD.

Conclusion: From the present findings, CBCT seems very effective in resolving conflicts and decreasing severity of symptoms of CHD among female cardiac patients.

Recommendations: CBCT can be considered as practicable method in managing marital conflicts associated with CHD.

Break: Networking & Refreshment Break 16:15-16:30 @ Foyer
Speaker
Biography:

S M Tajdit Rahman is a Resident Thoracic Surgeon of National Institute of Bangladesh. He has completed his MBBS from Sir Salimullah Medical College, Bangladesh and has a fascination for research in cardiac and thoracic diseases. He is doing research under renowned professors and has a great achievement in extracurricular activities. He is the Convener of first ever biomedical conference for students in Bangladesh. He has attended more than 15 national and international conferences.

Abstract:

Congenital cardiac disease is not uncommon in daily medical practice. Many studies have been carried out worldwide, showing incidence variation in different parts of the world as 5-10/1000 live birth. In Bangladesh, a mere study was done in this respect. This retrospective study was conducted from the records preserved in hospital register, compiled by the author from pediatric cardiology and cardiac surgery department over a period of 4 years extends from 2010-2013 in National Institute of Cardio Vascular Diseases Hospital. 6520 cases of live births weighing more than 1500gm and age over 28th weeks of gestational period were recorded by clinical examination and echocardiography with color Doppler. This study showed that 196 babies out of 6520 live births had CHD as 30/1000 live births. Study also expressed that higher incidence of CHD was observed in preterm baby than full term baby. Among the congenital heart lesions, atrial septal defect, ventricular septal defect, Patent ductus arteriosus, Tetralogy of Fallot`s, TGA were commonest having 20.41%, 13.78%, 10.71%, 8.67% and 4.59%, respectively. 15.81% of the patients had other associated somatic anomalies among which down syndrome was the commonest (7.14%). CHD of various patterns deserves crucial challenge among the newborns for management in Bangladesh. Various factors like high maternal age, drugs intake, antenatal infection, family history, gestational DM, down’s syndrome, mother having SLE are related to these diseases. Moreover, appropriate research can be accomplished taking large relevant sample gathering from different tertiary medical college hospitals to reveal actual scenario to prevent and treat the diseases.